Immucor Message Board - Msg: 3173500

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mason Barge who wrote ()	1/15/1998 3:38:00 AM
From: technetx	Read Replies (1) of 422

The earnings for the the 2nd Q just reported are not actually flat... 2nd Q last year >>> .0560 per share 2nd Q this year >>>> .0637 first 6 months last year >>>>>>>>> .1252 first 6 months this year>>>>>>>>>> .1301 Just thought someone had to mention this..... Also, As I understand it, the $1.2 M to be repaid by Wilms (or already repaid) is considered a "receivable" , so 1.2 M should be viewed as earnings for the 3rd Q; that comes to about $.14 per share additional earnings FOR THE QUARTER ! I understand it will be footnoted as an "extraordinary item" . But, in actuality, it's the profits that should have hit the bottom line a long time ago .. Dominic

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next